HLA Typing Transplant Diagnostics Services Market Report up to 2025| Top Key Players One Lambda, Proimmune Ltd., Creative Biolabs, Histogenetics LLC, The UCLA Immunogenetics Center

Data Bridge Market Research recently published Global HLA Typing Transplant Diagnostics Services Market study with an in-depth overview, describing the Product / Industry Scope and elaborates market outlook and status to 2025. The market Study is segmented by key regions that are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are One Lambda (Thermo Fischer Scientific, InC.), Proimmune Ltd., Creative Biolabs, Histogenetics LLC, The UCLA Immunogenetics Center, Admera Health, Quick Biology, New York Blood Center, The Sequencing Center, BloodCenter of Wisconsin, and Laboratory Corporation of America Holdings, Others.

Get Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hla-typing-transplant-diagnostics-services-market

Global HLA Typing Transplant Diagnostics Services Market is expected to reach USD 1,053.20 million by 2025 from USD 532.50 million in 2017, at a CAGR of 9.0% in the forecast period 2018 to 2025. Global HLA Typing Transplant Diagnostics Services Market, By Technology (Polymerase Chain Reaction {PCR-SSP, PCR SSOP, PCR-SBT}, Next-Generation Sequencing), End-User (Hospitals, Transplant Centers, Specialty Clinics, Academic Institutes), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2025

The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the global HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

Market Segmentation: Global HLA Typing Transplant Diagnostics Services Market

• The global HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) is expected to dominate the global HLA typing transplant diagnostics services market with 57.2% market share and is expected to reach USD 593.61 million by 2025, growing at a CAGR of 8.8% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) segment is expected to grow at the highest CAGR of 9.3% in the forecast period, to reach USD 459.59 million by 2025 from USD 227.14 million in 2017 in the forecast period 2018 to 2025.

• The polymerase chain reaction (PCR) is further sub-segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the global HLA typing transplant diagnostics services market with 49.9% market share and is expected to reach USD 514.76 million by 2025, with a CAGR of 8.7% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.6% in the forecast period, to reach USD 183.17 million by 2025 from USD 88.85 million in 2017 in the forecast period 2018 to 2025.

• The global HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the global HLA typing transplant diagnostics services market with 46.4% market share and is expected to reach USD 499.93 million by 2025, with the highest CAGR of 9.4% in the forecast period 2018 to 2025.

• Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.
Key Drivers: Global HLA Typing Transplant Diagnostics Services Market
Some of the major factors driving the market for global HLA typing transplant diagnostics services market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the global HLA typing transplant diagnostics services market.

On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

Key Points: Global HLA Typing Transplant Diagnostics Services Market

One Lambda (Thermo Fischer Scientific, InC.) is going to dominate the global HLA typing transplant diagnostics services market followed by Proimmune Ltd., Creative Biolabs, Histogenetics LLC, The UCLA Immunogenetics Center, Admera Health, Quick Biology, New York Blood Center, The Sequencing Center, BloodCenter of Wisconsin, and Laboratory Corporation of America Holdings

• The polymerase chain reaction (PCR) segment is dominating the global HLA typing transplant diagnostics services market.

• The next generation sequencing (NGS) segment is expected to grow with the highest CAGR of 9.0% in the forecast period 2018 to 2025.

Place purchase order for Global HLA Typing Transplant Diagnostics Services Market @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-hla-typing-transplant-diagnostics-services-market

Table of Contents:

1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY 1.2. MARKET DEFINITION 1.3. OVERVIEW OF GLOBAL HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET 1.4. CURRENCY AND PRICING 1.5. LIMITATION 1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. TECHNOLOGICAL ADVANCEMENTS IN HLA TYPING 3.1.2. INCREASING NUMBER OF SOLID ORGAN AND STEM CELL TRANSPLANTATION PROCEDURES 3.1.3. INCREASED RESEARCH GRANTS, FUNDS, AND PUBLIC-PRIVATE INVESTMENTS
3.2. RESTRAINTS
3.2.1. WEAK REIMBURSEMENTS FOR ORGAN DONATION AND TRANSPLANTATION PROCEDURES 3.2.2. EXPENSIVE NGS AND PCR-BASED DEVICES
3.3. OPPORTUNITIES
3.3.1. RISING HEALTHCARE INFRASTRUCTURE IN EMERGING NATIONS
3.4. CHALLENGES
3.4.1. SIGNIFICANT GAP BETWEEN NUMBER OF ORGANS DONATED AND ORGANS REQUIRED ANNUALLY 3.4.2. LACK OF TRAINED STAFF
4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.2. NEXT-GENERATION SEQUENCING (NGS)
6.3. POLYMERASE CHAIN REACTION (PCR)
6.3.1. PCR SSOP (SEQUENCE-SPECIFIC OLIGONUCLEOTIDE) 6.3.2. PCR SSP (SEQUENCE-SPECIFIC PRIMER) 6.3.3. PCR-SBT (SEQUENCING BASED TYPING)
7. GLOBAL HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY END-USER
7.1. OVERVIEW 7.2. SPECIALTY CLINICS 7.3. HOSPITALS 7.4. TRANSPLANT CENTERS 7.5. ACADEMIC INSTITUTES
8. GLOBAL HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. U.S. 8.2.2. CANADA 8.2.3. MEXICO
8.3. EUROPE
8.3.1. GERMANY 8.3.2. FRANCE 8.3.3. U.K. 8.3.4. ITALY 8.3.5. SPAIN 8.3.6. SWITZERLAND 8.3.7. NETHERLANDS 8.3.8. BELGIUM 8.3.9. RUSSIA 8.3.10. TURKEY 8.3.11. REST OF EUROPE
8.4. ASIA-PACIFIC
8.4.1. CHINA 8.4.2. JAPAN 8.4.3. INDIA 8.4.4. SOUTH KOREA 8.4.5. AUSTRALIA 8.4.6. SINGAPORE 8.4.7. THAILAND 8.4.8. MALAYSIA 8.4.9. INDONESIA 8.4.10. PHILIPPINES 8.4.11. REST OF ASIA-PACIFIC
8.5. SOUTH AMERICA
8.5.1. BRAZIL 8.5.2. REST OF SOUTH AMERICA
8.6. MIDDLE EAST & AFRICA
8.6.1. REST OF MIDDLE EAST AND AFRICA 8.6.2. SOUTH AFRICA
9. GLOBAL HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, COMPANY LANDSCAPE
9.1. COMPANY SHARE ANALYSIS: GLOBAL 9.2. COMPANY SHARE ANALYSIS: NORTH AMERICA 9.3. COMPANY SHARE ANALYSIS: EUROPE 9.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
10. COMPANY PROFILES
10.1. PROIMMUNE LTD.
10.1.1. COMPANY OVERVIEW 10.1.2. PROIMMUNE LTD.: COMPANY SNAPSHOT 10.1.3. PRODUCT PORTFOLIO 10.1.4. RECENT DEVELOPMENTS
10.2. CREATIVE BIOLABS
10.2.1. COMPANY OVERVIEW 10.2.2. CREATIVE BIOLABS: COMPANY SNAPSHOT 10.2.3. PRODUCT PORTFOLIO 10.2.4. RECENT DEVELOPMENTS
10.3. HISTOGENETICS LLC
10.3.1. COMPANY OVERVIEW 10.3.2. HISTOGENETICS LLC: COMPANY SNAPSHOT 10.3.3. PRODUCT PORTFOLIO 10.3.4. RECENT DEVELOPMENTS
10.4. THE UCLA IMMUNOGENETICS CENTER
10.4.1. COMPANY OVERVIEW 10.4.2. THE UCLA IMMUNOGENETICS CENTER: COMPANY SNAPSHOT 10.4.3. PRODUCT PORTFOLIO 10.4.4. RECENT DEVELOPMENTS
10.5. ADMERA HEALTH
10.5.1. COMPANY OVERVIEW 10.5.2. ADMERA HEALTH: COMPANY SNAPSHOT 10.5.3. PRODUCT PORTFOLIO 10.5.4. RECENT DEVELOPMENTS
10.6. QUICK BIOLOGY
10.6.1. COMPANY OVERVIEW 10.6.2. QUICK BIOLOGY: COMPANY SNAPSHOT 10.6.3. PRODUCT PORTFOLIO 10.6.4. RECENT DEVELOPMENTS
10.7. NEW YORK BLOOD CENTER
10.7.1. COMPANY OVERVIEW 10.7.2. NEW YORK BLOOD CENTER: COMPANY SNAPSHOT 10.7.3. PRODUCT PORTFOLIO 10.7.4. RECENT DEVELOPMENTS
10.8. THE SEQUENCING CENTER
10.8.1. COMPANY OVERVIEW 10.8.2. THE SEQUENCING CENTER: COMPANY SNAPSHOT 10.8.3. PRODUCT PORTFOLIO 10.8.4. RECENT DEVELOPMENTS
10.9. BLOODCENTER OF WISCONSIN
10.9.1. COMPANY OVERVIEW 10.9.2. BLOODCENTER OF WISCONSIN: COMPANY SNAPSHOT 10.9.3. PRODUCT PORTFOLIO 10.9.4. RECENT DEVELOPMENTS
10.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
10.10.1. COMPANY OVERVIEW 10.10.2. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE ANALYSIS 10.10.3. PRODUCT PORTFOLIO 10.10.4. RECENT DEVELOPMENTS
10.11. THERMO FISHER SCIENTIFIC INC.
10.11.1. COMPANY OVERVIEW 10.11.2. THERMO FISHER SCIENTIFIC INC. :REVENUE ANALYSIS 10.11.3. PRODUCT PORTFOLIO 10.11.4. RECENT DEVELOPMENTS

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-hla-typing-transplant-diagnostics-services-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.